Filing Details
LIFECORE BIOMEDICAL, INC. \DE\ (NASDAQ:LFCR) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:LFCR
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Reports Material Event to SEC
Filing Details LIFECORE BIOMEDICAL, INC. \DE\ (NASDAQ:LFCR) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market…
Market Context
LIFECORE BIOMEDICAL, INC. \DE\'s stock currently trades at $5.09 with a market capitalization of $292.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for LIFECORE BIOMEDICAL, INC. \DE\'s stock.
All SEC filings for LIFECORE BIOMEDICAL, INC. \DE\ are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LFCR Stock Page
Frequently Asked Questions
Where can I read LFCR's SEC filings?
Browse all filings on our LFCR SEC filings page.
What types of SEC filings does LIFECORE BIOMEDICAL, INC. \DE\ file?
Public companies like LIFECORE BIOMEDICAL, INC. \DE\ file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.